Court Injunction Temporarily Upends Most Favored Nation Policy To Lower Prices Of Medicare Part B Drugs

It’s quite conceivable the Biden Administration would wish to implement some kind of partial realignment of Medicare drug prices based on an international pricing index. This wouldn’t happen, however, by way of an executive order, but rather through Congress.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive